These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 871524)

  • 1. Unique pattern of fibrinogen cleavage by human leukocyte proteases.
    Bilezikian SB; Nossel HL
    Blood; 1977 Jul; 50(1):21-8. PubMed ID: 871524
    [No Abstract]   [Full Text] [Related]  

  • 2. Disseminated intravascular coagulation: the application and utility of diagnostic tests.
    Ockelford PA; Carter CJ
    Semin Thromb Hemost; 1982 Jul; 8(3):198-216. PubMed ID: 6215711
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of fibrinopeptide A and B beta 15-42 analysis in blood coagulo-fibrinolytic tests].
    Koshihara K; Fuzimaki M
    Nihon Rinsho; 1989 Dec; 48 Suppl():889-91. PubMed ID: 2622023
    [No Abstract]   [Full Text] [Related]  

  • 4. [Plasma fibrinopeptide A and fibrinopeptide B beta 15-42 levels in patients with Behçet's disease].
    Sunakawa M; Arai I; Okinami S
    Nippon Ganka Gakkai Zasshi; 1986 Jun; 90(6):871-4. PubMed ID: 3751789
    [No Abstract]   [Full Text] [Related]  

  • 5. Low solubility fibrinogen examined by two-dimensional sodium dodecyl sulfate gel electrophoresis and isoelectric focusing.
    Weinstein MJ; Deykin D
    Thromb Res; 1978 Sep; 13(3):361-77. PubMed ID: 741433
    [No Abstract]   [Full Text] [Related]  

  • 6. Progress in the measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Clin Pathol; 1984; 9():15-45. PubMed ID: 6229812
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fibrinopeptide A (FPA), fibrinopeptide B (FPB) and fibrinopeptide Bbeta(15-42) (FPBbeta15-42)].
    Uchiba M; Okajima K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():615-7. PubMed ID: 15658404
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical significance of fibrinogen/fibrin degradation products (F/F DP)].
    Alakhverdian R
    Vutr Boles; 1979; 18(3):160-7. PubMed ID: 89851
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinogen Aarhus--a new case of dysfibrinogenemia.
    Hessel B; Stenbjerg S; Dyr J; Kudryk B; Therkildsen L; Blombäck B
    Thromb Res; 1986 Apr; 42(1):21-37. PubMed ID: 2939591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood coagulation and fibrinolysis in anesthesia and operations, with special reference to FPA, FPB beta 15-42].
    Gando S; Tedo I; Hanaoka Y; Makise N; Tsujinaga H; Kubota M
    Masui; 1988 Apr; 37(4):451-6. PubMed ID: 3398226
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serial changes in FPA and FPB beta 15-42 during surgery with cardiopulmonary bypass].
    Gando S; Tedo I; Tsujinaga H; Kubota M
    Masui; 1988 May; 37(5):541-5. PubMed ID: 3411777
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of acid-base balance and Apgar score on fibrinopeptide A and fibrinopeptide B beta 15-42 in umbilical cord blood].
    Ogura H; Adachi H; Takeda T; Nakagomi H; Kanno S; Yokoyama M; Kinoshita T
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):128-34. PubMed ID: 3102647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of human fibrinopeptides by high-performance liquid chromatography.
    Kehl M; Lottspeich F; Henschen A
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1661-4. PubMed ID: 7319478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoassay of human fibrinopeptides.
    Butler VP; Nossel HL; Canfield RE
    Methods Enzymol; 1982; 84():102-18. PubMed ID: 7048006
    [No Abstract]   [Full Text] [Related]  

  • 15. Structural considerations of plasmic degradation of fibrinogen.
    Marder VJ; Budzynski AZ
    Pathol Biol (Paris); 1974 Nov; 22 suppl():43-6. PubMed ID: 4283397
    [No Abstract]   [Full Text] [Related]  

  • 16. [Coagulation-fibrinolysis abnormalities in acute stage hypertensive intra-cerebral hemorrhage and head injury (preliminary report). With special reference to fibrinopeptides A and B beta 15-42].
    Touho H; Hino A; Suzuki K; Kubo S; Hirakawa K
    Neurol Med Chir (Tokyo); 1985 Mar; 25(3):203-8. PubMed ID: 2409465
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma concentrations of fibrinopeptide A and fibrinopeptide B beta 15-42 in glomerulonephritis and the nephrotic syndrome.
    Tomura S; Oono Y; Kuriyama R; Takeuchi J
    Arch Intern Med; 1985 Jun; 145(6):1033-5. PubMed ID: 4004427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying thrombin-catalyzed release of fibrinopeptides from fibrinogen using high-performance liquid chromatography.
    Ng AS; Lewis SD; Shafer JA
    Methods Enzymol; 1993; 222():341-58. PubMed ID: 8412803
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrinopeptide-releasing enzymes in the venom from the southern copperhead snake (Agkistrodon contortrix contortrix).
    Dyr JE; Hessel B; Suttnar J; Kornalík F; Blombäck B
    Toxicon; 1989; 27(3):359-73. PubMed ID: 2728027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin and plasmin activity in coronary artery disease.
    Small M; Lowe GD; Douglas JT; Hutton I; Lorimer AR; Forbes CD
    Br Heart J; 1988 Sep; 60(3):201-3. PubMed ID: 2972304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.